Sherbrooke, Canada

Pierre Deslongchamps


 


Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • Québec, CA (2009 - 2013)
  • North Hatley, CA (2007 - 2015)
  • Sherbrooke, CA (2008 - 2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Pierre Deslongchamps: A Pioneer in Macrocyclic Compounds

Introduction: Pierre Deslongchamps, an esteemed inventor based in Sherbrooke, Canada, has made significant contributions to the field of drug discovery. With a total of 9 patents to his name, Deslongchamps has established himself as a key figure in the development of innovative compounds that have implications in pharmaceuticals.

Latest Patents: Among his latest achievements, Deslongchamps has focused on the combinatorial synthesis of libraries of macrocyclic compounds. These compounds are useful in drug discovery and are represented by the formula (I). His pioneering work in this area highlights his commitment to advancing medicinal chemistry and finding new solutions in healthcare.

Career Highlights: Throughout his career, Pierre Deslongchamps has worked with notable companies, including Tranzyme Pharma Inc. and Ocera Therapeutics, Inc. His expertise in synthesizing complex molecular structures has been instrumental in various research projects aimed at enhancing drug efficacy and safety.

Collaborations: Deslongchamps has collaborated with distinguished colleagues in his field, including Yves Dory and Luc Ouellet. These partnerships have fostered a dynamic environment for creativity and innovation, leading to breakthroughs that push the boundaries of modern pharmaceuticals.

Conclusion: Pierre Deslongchamps continues to make strides in the realm of drug discovery through his inventive work with macrocyclic compounds. His extensive patent portfolio and active collaborations underscore his vital role in advancing medical research, paving the way for future innovations in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…